Wikidata

(Q63318297)

English

Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy

clinical trial

In more languages

Statements

short name
EARLiMS (English)
0 references
title
A Multi-centre, Open-label, Non-randomised, Parallel Group Clinical Trial to Assess the Efficacy of Fingolimod in Naive Patients Versus Fingolimod in Patients Previously Treated With Interferons or Glatiramer Acetate, Based on the Presence of Relapses in Patients With Relapsing-remitting Multiple Sclerosis. (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
sponsor
Novartis
0 references
country
Australia
0 references
Spain
0 references
start time
24 December 2011
0 references
end time
26 December 2015
0 references
number of participants
347
0 references
research site
Novartis
0 references
minimum age
18 year
0 references
maximum age
50 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63318297&oldid=2129407042"